X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (343) 343
Book Review (49) 49
Conference Proceeding (22) 22
Publication (14) 14
Book Chapter (12) 12
Book / eBook (4) 4
Newspaper Article (3) 3
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (155) 155
humans (154) 154
gastroenterology & hepatology (105) 105
male (95) 95
female (89) 89
hepatitis c, chronic - drug therapy (78) 78
gastroenterology and hepatology (77) 77
middle aged (77) 77
antiviral agents - therapeutic use (76) 76
hepatitis c (73) 73
adult (68) 68
hepacivirus - genetics (59) 59
hepatitis c virus (58) 58
drug therapy, combination (54) 54
treatment outcome (52) 52
hepatitis (49) 49
genotype (47) 47
abridged index medicus (45) 45
ribavirin (40) 40
ribavirin - therapeutic use (40) 40
antiviral agents - adverse effects (39) 39
health aspects (39) 39
hepatitis c, chronic - virology (39) 39
interferon (39) 39
aged (33) 33
care and treatment (33) 33
interferon-alpha - therapeutic use (33) 33
antiviral agents - administration & dosage (32) 32
drug therapy (31) 31
virus-infection (28) 28
medicine, general & internal (26) 26
polyethylene glycols - therapeutic use (26) 26
antiviral agents (25) 25
ribavirin - administration & dosage (25) 25
viral load (25) 25
plus ribavirin (24) 24
rna, viral - blood (24) 24
infectious diseases (23) 23
interferon-alpha - administration & dosage (23) 23
recombinant proteins (23) 23
sofosbuvir (23) 23
genotype & phenotype (22) 22
hepatitis b (22) 22
infections (22) 22
ribavirin - adverse effects (22) 22
telaprevir (22) 22
biological response modifiers (21) 21
hepacivirus - drug effects (21) 21
liver (21) 21
hepatitis c - drug therapy (20) 20
sustained virological response (20) 20
therapy (20) 20
infection (19) 19
analysis (18) 18
young adult (18) 18
cirrhosis (17) 17
combination therapy (17) 17
diagnosis (17) 17
hepatocellular-carcinoma (17) 17
immunology (17) 17
interferon-alpha - adverse effects (17) 17
polyethylene glycols - administration & dosage (17) 17
clinical trials (16) 16
hepatology (16) 16
medical colleges (16) 16
peginterferon alpha-2a (16) 16
research (16) 16
united-states (16) 16
chronic hepatitis-c (15) 15
genetic aspects (15) 15
genotype 1 infection (15) 15
genotypes (15) 15
hepatitis b, chronic - drug therapy (15) 15
liver cirrhosis (15) 15
patients (15) 15
recombinant proteins - administration & dosage (15) 15
recombinant proteins - therapeutic use (15) 15
boceprevir (14) 14
hcv (14) 14
liver diseases (14) 14
oligopeptides - therapeutic use (14) 14
protease inhibitors (14) 14
risk factors (14) 14
uridine monophosphate - analogs & derivatives (14) 14
virology (14) 14
adolescent (13) 13
hepacivirus - isolation & purification (13) 13
medical research (13) 13
polyethylene glycols - adverse effects (13) 13
protease inhibitor (13) 13
randomized-trial (13) 13
combination (12) 12
drug administration schedule (12) 12
peginterferon (12) 12
proline - analogs & derivatives (12) 12
recurrence (12) 12
chronic infection (11) 11
double-blind method (11) 11
drug resistance, viral (11) 11
gastroenterology (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1989, Current topics in gastroenterology., ISBN 9780444014832, xii, 271 p., [4] p. of plates
Book
2007, Clinics in liver disease, ISBN 9781416050513, Volume 11, no. 4., xv, p. 685-997
Book
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 06/2019, Volume 49, Issue 12, pp. 1530 - 1530
Linked Content This article is linked to Robles‐Diaz et al paper. To view this article, visit https://doi.org/10.1111/apt.15211 . 
Bodybuilders | Bodybuilding
Journal Article
Gastroenterology & hepatology, ISSN 1554-7914, 10/2016, Volume 12, Issue 10 Suppl 4, pp. 1 - 11
The US Food and Drug Administration has now approved 10 direct-acting antivirals (DAAs) for the management of hepatitis C virus (HCV). These therapies are... 
Journal Article
Gastroenterology & Hepatology, ISSN 1554-7914, 10/2016, Volume 12, Issue 10 Suppl 4, pp. 1 - 11
The US Food and Drug Administration has now approved 10 direct-acting antivirals (DAAs) for the management of hepatitis C virus (HCV). These therapies are... 
CMExpress Opportunity
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2018, Volume 113, Issue Supplement, pp. S461 - S462
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2018, Volume 113, Issue Supplement, pp. S462 - S463
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2018, Volume 113, Issue Supplement, p. S549
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 2014, Volume 370, Issue 16, pp. 1560 - 1561
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2017, Volume 112, p. S1467
Journal Article
Expert review of gastroenterology & hepatology, 09/2017, Volume 11, Issue 9, p. 789
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 27, pp. 2599 - 2607
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9865, pp. 468 - 475
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9941, pp. 403 - 413
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.